nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—chronic obstructive pulmonary disease—asthma	0.158	1	CtDrD
Salbutamol—ADRB2—asthma	0.0565	1	CbGaD
Salbutamol—Salmeterol—asthma	0.0524	0.252	CrCtD
Salbutamol—Adrenergic beta2-Agonists—Indacaterol—asthma	0.0509	0.181	CiPCiCtD
Salbutamol—Adrenergic beta2-Agonists—Salmeterol—asthma	0.0509	0.181	CiPCiCtD
Salbutamol—Adrenergic beta2-Agonists—Pirbuterol—asthma	0.0509	0.181	CiPCiCtD
Salbutamol—Adrenergic beta2-Agonists—Orciprenaline—asthma	0.0509	0.181	CiPCiCtD
Salbutamol—Pirbuterol—asthma	0.0487	0.234	CrCtD
Salbutamol—Terbutaline—asthma	0.0397	0.191	CrCtD
Salbutamol—Adrenergic beta2-Agonists—Formoterol—asthma	0.0386	0.137	CiPCiCtD
Salbutamol—Adrenergic beta2-Agonists—Arformoterol—asthma	0.0386	0.137	CiPCiCtD
Salbutamol—Isoetarine—asthma	0.0382	0.184	CrCtD
Salbutamol—Isoprenaline—asthma	0.029	0.139	CrCtD
Salbutamol—ADRB2—Orciprenaline—asthma	0.0128	0.102	CbGbCtD
Salbutamol—Clenbuterol—Pirbuterol—asthma	0.0107	0.0837	CrCrCtD
Salbutamol—ADRB2—Pirbuterol—asthma	0.0097	0.0773	CbGbCtD
Salbutamol—ADRB2—Isoetarine—asthma	0.0097	0.0773	CbGbCtD
Salbutamol—ADRB2—Terbutaline—asthma	0.0097	0.0773	CbGbCtD
Salbutamol—ADRB1—Isoetarine—asthma	0.00955	0.0761	CbGbCtD
Salbutamol—ADRB1—Pirbuterol—asthma	0.00955	0.0761	CbGbCtD
Salbutamol—Clenbuterol—Terbutaline—asthma	0.00875	0.0683	CrCrCtD
Salbutamol—Pirbuterol—Terbutaline—asthma	0.00756	0.059	CrCrCtD
Salbutamol—Nadolol—Pirbuterol—asthma	0.00737	0.0575	CrCrCtD
Salbutamol—ADRB2—Indacaterol—asthma	0.00672	0.0536	CbGbCtD
Salbutamol—ADRB1—Indacaterol—asthma	0.00662	0.0528	CbGbCtD
Salbutamol—Phenylephrine—Orciprenaline—asthma	0.0063	0.0492	CrCrCtD
Salbutamol—ADRB2—Salmeterol—asthma	0.00625	0.0498	CbGbCtD
Salbutamol—Terbutaline—Pirbuterol—asthma	0.00616	0.0481	CrCrCtD
Salbutamol—Terbutaline—Orciprenaline—asthma	0.0058	0.0452	CrCrCtD
Salbutamol—Phenylephrine—Terbutaline—asthma	0.00547	0.0427	CrCrCtD
Salbutamol—Isoetarine—Orciprenaline—asthma	0.00537	0.0419	CrCrCtD
Salbutamol—Bupranolol—Pirbuterol—asthma	0.00533	0.0416	CrCrCtD
Salbutamol—ADRB2—Isoprenaline—asthma	0.00531	0.0424	CbGbCtD
Salbutamol—ADRB1—Isoprenaline—asthma	0.00523	0.0417	CbGbCtD
Salbutamol—ADRB2—Arformoterol—asthma	0.00474	0.0378	CbGbCtD
Salbutamol—ADRB2—Formoterol—asthma	0.00474	0.0378	CbGbCtD
Salbutamol—ADRB1—Arformoterol—asthma	0.00466	0.0372	CbGbCtD
Salbutamol—ADRB1—Formoterol—asthma	0.00466	0.0372	CbGbCtD
Salbutamol—Bupranolol—Terbutaline—asthma	0.00434	0.0339	CrCrCtD
Salbutamol—Norepinephrine—Isoetarine—asthma	0.00418	0.0326	CrCrCtD
Salbutamol—Epinephrine—Pirbuterol—asthma	0.00403	0.0315	CrCrCtD
Salbutamol—Phenylephrine—Isoprenaline—asthma	0.00399	0.0311	CrCrCtD
Salbutamol—Levonordefrin—Isoetarine—asthma	0.00392	0.0306	CrCrCtD
Salbutamol—Epinephrine—Orciprenaline—asthma	0.00379	0.0296	CrCrCtD
Salbutamol—Terbutaline—Isoprenaline—asthma	0.00367	0.0286	CrCrCtD
Salbutamol—Isoetarine—Isoprenaline—asthma	0.0034	0.0265	CrCrCtD
Salbutamol—Epinephrine—Terbutaline—asthma	0.00329	0.0256	CrCrCtD
Salbutamol—Norepinephrine—Isoprenaline—asthma	0.00317	0.0247	CrCrCtD
Salbutamol—Epinephrine—Isoetarine—asthma	0.00316	0.0247	CrCrCtD
Salbutamol—Isoprenaline—Orciprenaline—asthma	0.00308	0.0241	CrCrCtD
Salbutamol—Levonordefrin—Isoprenaline—asthma	0.00297	0.0232	CrCrCtD
Salbutamol—Isoprenaline—Terbutaline—asthma	0.00267	0.0209	CrCrCtD
Salbutamol—Isoprenaline—Isoetarine—asthma	0.00257	0.0201	CrCrCtD
Salbutamol—Epinephrine—Isoprenaline—asthma	0.0024	0.0187	CrCrCtD
Salbutamol—Isoprenaline—Arformoterol—asthma	0.00234	0.0182	CrCrCtD
Salbutamol—Isoprenaline—Formoterol—asthma	0.00234	0.0182	CrCrCtD
Salbutamol—CYP3A4—Fluticasone furoate—asthma	0.00131	0.0105	CbGbCtD
Salbutamol—CYP3A4—Budesonide—asthma	0.00117	0.00934	CbGbCtD
Salbutamol—CYP3A4—Ciclesonide—asthma	0.00107	0.00855	CbGbCtD
Salbutamol—CYP3A4—Indacaterol—asthma	0.00107	0.00855	CbGbCtD
Salbutamol—CYP3A4—Salmeterol—asthma	0.000996	0.00794	CbGbCtD
Salbutamol—CYP3A4—Flunisolide—asthma	0.000996	0.00794	CbGbCtD
Salbutamol—CYP3A4—Ipratropium bromide—asthma	0.000888	0.00708	CbGbCtD
Salbutamol—CYP3A4—Zileuton—asthma	0.000888	0.00708	CbGbCtD
Salbutamol—CYP3A4—Fluticasone Propionate—asthma	0.000847	0.00675	CbGbCtD
Salbutamol—CYP3A4—Zafirlukast—asthma	0.000782	0.00623	CbGbCtD
Salbutamol—CYP3A4—Tiotropium—asthma	0.000673	0.00537	CbGbCtD
Salbutamol—CYP3A4—Aminophylline—asthma	0.000642	0.00512	CbGbCtD
Salbutamol—CYP3A4—Theophylline—asthma	0.000604	0.00481	CbGbCtD
Salbutamol—CYP3A4—Montelukast—asthma	0.000572	0.00456	CbGbCtD
Salbutamol—CYP3A4—Loratadine—asthma	0.000572	0.00456	CbGbCtD
Salbutamol—CYP3A4—Methylprednisolone—asthma	0.000523	0.00417	CbGbCtD
Salbutamol—CYP3A4—Triamcinolone—asthma	0.000397	0.00316	CbGbCtD
Salbutamol—CYP3A4—Betamethasone—asthma	0.00034	0.00271	CbGbCtD
Salbutamol—CYP3A4—Prednisolone—asthma	0.000336	0.00268	CbGbCtD
Salbutamol—CYP3A4—Hydrocortisone—asthma	0.000318	0.00254	CbGbCtD
Salbutamol—CYP3A4—Prednisone—asthma	0.000317	0.00253	CbGbCtD
Salbutamol—CYP3A4—Dexamethasone—asthma	0.000198	0.00158	CbGbCtD
Salbutamol—Pirbuterol—ADRB2—asthma	7.51e-05	0.113	CrCbGaD
Salbutamol—Levobunolol—ADRB2—asthma	6.7e-05	0.101	CrCbGaD
Salbutamol—Terbutaline—ADRB2—asthma	6.13e-05	0.092	CrCbGaD
Salbutamol—Isoetarine—ADRB2—asthma	5.9e-05	0.0886	CrCbGaD
Salbutamol—Carteolol—ADRB2—asthma	5.69e-05	0.0855	CrCbGaD
Salbutamol—Clenbuterol—TNF—asthma	5.53e-05	0.083	CrCbGaD
Salbutamol—Salmeterol—ADRB2—asthma	5.21e-05	0.0782	CrCbGaD
Salbutamol—Nadolol—ADRB2—asthma	5.08e-05	0.0762	CrCbGaD
Salbutamol—Clenbuterol—ADRB2—asthma	4.9e-05	0.0736	CrCbGaD
Salbutamol—Bupranolol—ADRB2—asthma	4.84e-05	0.0727	CrCbGaD
Salbutamol—Isoprenaline—ADRB2—asthma	2.45e-05	0.0368	CrCbGaD
Salbutamol—Epinephrine—TNF—asthma	2.32e-05	0.0349	CrCbGaD
Salbutamol—Norepinephrine—ADRB2—asthma	2.27e-05	0.0341	CrCbGaD
Salbutamol—Epinephrine—ADRB2—asthma	2.06e-05	0.0309	CrCbGaD
Salbutamol—Syncope—Triamcinolone—asthma	4.43e-06	0.000121	CcSEcCtD
Salbutamol—Vertigo—Methylprednisolone—asthma	4.43e-06	0.000121	CcSEcCtD
Salbutamol—Syncope—Methylprednisolone—asthma	4.42e-06	0.000121	CcSEcCtD
Salbutamol—Discomfort—Hydrocortisone—asthma	4.42e-06	0.00012	CcSEcCtD
Salbutamol—Connective tissue disorder—Prednisone—asthma	4.41e-06	0.00012	CcSEcCtD
Salbutamol—Nausea—Budesonide—asthma	4.4e-06	0.00012	CcSEcCtD
Salbutamol—Oedema—Prednisolone—asthma	4.39e-06	0.00012	CcSEcCtD
Salbutamol—Anaphylactic shock—Prednisolone—asthma	4.39e-06	0.00012	CcSEcCtD
Salbutamol—Loss of consciousness—Triamcinolone—asthma	4.35e-06	0.000119	CcSEcCtD
Salbutamol—Loss of consciousness—Methylprednisolone—asthma	4.34e-06	0.000118	CcSEcCtD
Salbutamol—Shock—Prednisolone—asthma	4.32e-06	0.000118	CcSEcCtD
Salbutamol—Cough—Triamcinolone—asthma	4.31e-06	0.000118	CcSEcCtD
Salbutamol—Anaphylactic shock—Hydrocortisone—asthma	4.29e-06	0.000117	CcSEcCtD
Salbutamol—Oedema—Hydrocortisone—asthma	4.29e-06	0.000117	CcSEcCtD
Salbutamol—Tachycardia—Prednisolone—asthma	4.28e-06	0.000117	CcSEcCtD
Salbutamol—Hypertension—Triamcinolone—asthma	4.27e-06	0.000116	CcSEcCtD
Salbutamol—Hypertension—Methylprednisolone—asthma	4.26e-06	0.000116	CcSEcCtD
Salbutamol—Infection—Hydrocortisone—asthma	4.26e-06	0.000116	CcSEcCtD
Salbutamol—Hyperhidrosis—Prednisolone—asthma	4.24e-06	0.000116	CcSEcCtD
Salbutamol—Shock—Hydrocortisone—asthma	4.22e-06	0.000115	CcSEcCtD
Salbutamol—Myalgia—Triamcinolone—asthma	4.21e-06	0.000115	CcSEcCtD
Salbutamol—Nervous system disorder—Hydrocortisone—asthma	4.2e-06	0.000115	CcSEcCtD
Salbutamol—Myalgia—Methylprednisolone—asthma	4.2e-06	0.000115	CcSEcCtD
Salbutamol—Arthralgia—Methylprednisolone—asthma	4.2e-06	0.000115	CcSEcCtD
Salbutamol—Anxiety—Methylprednisolone—asthma	4.19e-06	0.000114	CcSEcCtD
Salbutamol—Tachycardia—Hydrocortisone—asthma	4.18e-06	0.000114	CcSEcCtD
Salbutamol—Flushing—Prednisone—asthma	4.17e-06	0.000114	CcSEcCtD
Salbutamol—Skin disorder—Hydrocortisone—asthma	4.16e-06	0.000114	CcSEcCtD
Salbutamol—Ill-defined disorder—Betamethasone—asthma	4.16e-06	0.000114	CcSEcCtD
Salbutamol—Ill-defined disorder—Dexamethasone—asthma	4.16e-06	0.000114	CcSEcCtD
Salbutamol—Discomfort—Triamcinolone—asthma	4.16e-06	0.000113	CcSEcCtD
Salbutamol—Discomfort—Methylprednisolone—asthma	4.15e-06	0.000113	CcSEcCtD
Salbutamol—Hyperhidrosis—Hydrocortisone—asthma	4.14e-06	0.000113	CcSEcCtD
Salbutamol—Dry mouth—Triamcinolone—asthma	4.12e-06	0.000112	CcSEcCtD
Salbutamol—Angioedema—Dexamethasone—asthma	4.1e-06	0.000112	CcSEcCtD
Salbutamol—Angioedema—Betamethasone—asthma	4.1e-06	0.000112	CcSEcCtD
Salbutamol—Anorexia—Hydrocortisone—asthma	4.09e-06	0.000111	CcSEcCtD
Salbutamol—Angiopathy—Prednisone—asthma	4.07e-06	0.000111	CcSEcCtD
Salbutamol—Immune system disorder—Prednisone—asthma	4.05e-06	0.000111	CcSEcCtD
Salbutamol—Malaise—Betamethasone—asthma	4.05e-06	0.00011	CcSEcCtD
Salbutamol—Malaise—Dexamethasone—asthma	4.05e-06	0.00011	CcSEcCtD
Salbutamol—Oedema—Triamcinolone—asthma	4.04e-06	0.00011	CcSEcCtD
Salbutamol—Anaphylactic shock—Triamcinolone—asthma	4.04e-06	0.00011	CcSEcCtD
Salbutamol—Vertigo—Betamethasone—asthma	4.03e-06	0.00011	CcSEcCtD
Salbutamol—Vertigo—Dexamethasone—asthma	4.03e-06	0.00011	CcSEcCtD
Salbutamol—Anaphylactic shock—Methylprednisolone—asthma	4.03e-06	0.00011	CcSEcCtD
Salbutamol—Syncope—Betamethasone—asthma	4.02e-06	0.00011	CcSEcCtD
Salbutamol—Syncope—Dexamethasone—asthma	4.02e-06	0.00011	CcSEcCtD
Salbutamol—Arrhythmia—Prednisone—asthma	4.01e-06	0.000109	CcSEcCtD
Salbutamol—Infection—Triamcinolone—asthma	4.01e-06	0.000109	CcSEcCtD
Salbutamol—Hypotension—Hydrocortisone—asthma	4e-06	0.000109	CcSEcCtD
Salbutamol—Infection—Methylprednisolone—asthma	4e-06	0.000109	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—CXCR3—asthma	3.99e-06	0.000733	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GSTP1—asthma	3.98e-06	0.000732	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPS—asthma	3.98e-06	0.000732	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TAC1—asthma	3.98e-06	0.000732	CbGpPWpGaD
Salbutamol—Shock—Triamcinolone—asthma	3.97e-06	0.000108	CcSEcCtD
Salbutamol—Insomnia—Prednisolone—asthma	3.97e-06	0.000108	CcSEcCtD
Salbutamol—Shock—Methylprednisolone—asthma	3.96e-06	0.000108	CcSEcCtD
Salbutamol—Nervous system disorder—Methylprednisolone—asthma	3.95e-06	0.000108	CcSEcCtD
Salbutamol—Loss of consciousness—Dexamethasone—asthma	3.94e-06	0.000108	CcSEcCtD
Salbutamol—Loss of consciousness—Betamethasone—asthma	3.94e-06	0.000108	CcSEcCtD
Salbutamol—Paraesthesia—Prednisolone—asthma	3.94e-06	0.000107	CcSEcCtD
Salbutamol—Tachycardia—Triamcinolone—asthma	3.94e-06	0.000107	CcSEcCtD
Salbutamol—Mental disorder—Prednisone—asthma	3.93e-06	0.000107	CcSEcCtD
Salbutamol—Tachycardia—Methylprednisolone—asthma	3.93e-06	0.000107	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—BDKRB2—asthma	3.93e-06	0.000723	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTP1—asthma	3.93e-06	0.000722	CbGpPWpGaD
Salbutamol—Skin disorder—Methylprednisolone—asthma	3.91e-06	0.000107	CcSEcCtD
Salbutamol—Malnutrition—Prednisone—asthma	3.91e-06	0.000107	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Hydrocortisone—asthma	3.9e-06	0.000107	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CXCR3—asthma	3.9e-06	0.000717	CbGpPWpGaD
Salbutamol—Hyperhidrosis—Triamcinolone—asthma	3.9e-06	0.000106	CcSEcCtD
Salbutamol—Hyperhidrosis—Methylprednisolone—asthma	3.89e-06	0.000106	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—ADCY2—asthma	3.89e-06	0.000715	CbGpPWpGaD
Salbutamol—Insomnia—Hydrocortisone—asthma	3.88e-06	0.000106	CcSEcCtD
Salbutamol—Hypertension—Dexamethasone—asthma	3.87e-06	0.000106	CcSEcCtD
Salbutamol—Hypertension—Betamethasone—asthma	3.87e-06	0.000106	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—IL3—asthma	3.87e-06	0.000712	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	3.87e-06	0.000711	CbGpPWpGaD
Salbutamol—Paraesthesia—Hydrocortisone—asthma	3.85e-06	0.000105	CcSEcCtD
Salbutamol—Myalgia—Betamethasone—asthma	3.82e-06	0.000104	CcSEcCtD
Salbutamol—Myalgia—Dexamethasone—asthma	3.82e-06	0.000104	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—POMC—asthma	3.81e-06	0.0007	CbGpPWpGaD
Salbutamol—Anxiety—Betamethasone—asthma	3.81e-06	0.000104	CcSEcCtD
Salbutamol—Anxiety—Dexamethasone—asthma	3.81e-06	0.000104	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—ADCY2—asthma	3.8e-06	0.000699	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL3—asthma	3.79e-06	0.000697	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	3.78e-06	0.000696	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL5—asthma	3.78e-06	0.000695	CbGpPWpGaD
Salbutamol—Discomfort—Dexamethasone—asthma	3.77e-06	0.000103	CcSEcCtD
Salbutamol—Discomfort—Betamethasone—asthma	3.77e-06	0.000103	CcSEcCtD
Salbutamol—Dyspepsia—Hydrocortisone—asthma	3.77e-06	0.000103	CcSEcCtD
Salbutamol—Hypotension—Methylprednisolone—asthma	3.76e-06	0.000103	CcSEcCtD
Salbutamol—Pain—Prednisolone—asthma	3.75e-06	0.000102	CcSEcCtD
Salbutamol—Decreased appetite—Hydrocortisone—asthma	3.73e-06	0.000102	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—CCL2—asthma	3.73e-06	0.000685	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—POMC—asthma	3.72e-06	0.000685	CbGpPWpGaD
Salbutamol—Gastrointestinal disorder—Hydrocortisone—asthma	3.7e-06	0.000101	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—IL5—asthma	3.7e-06	0.00068	CbGpPWpGaD
Salbutamol—Fatigue—Hydrocortisone—asthma	3.69e-06	0.000101	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Triamcinolone—asthma	3.68e-06	0.0001	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Methylprednisolone—asthma	3.67e-06	0.0001	CcSEcCtD
Salbutamol—Pain—Hydrocortisone—asthma	3.66e-06	0.0001	CcSEcCtD
Salbutamol—Oedema—Dexamethasone—asthma	3.66e-06	9.99e-05	CcSEcCtD
Salbutamol—Anaphylactic shock—Betamethasone—asthma	3.66e-06	9.99e-05	CcSEcCtD
Salbutamol—Oedema—Betamethasone—asthma	3.66e-06	9.99e-05	CcSEcCtD
Salbutamol—Anaphylactic shock—Dexamethasone—asthma	3.66e-06	9.99e-05	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—GSTM1—asthma	3.66e-06	0.000673	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KIF3A—asthma	3.66e-06	0.000672	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4A—asthma	3.66e-06	0.000672	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—KNG1—asthma	3.65e-06	0.000672	CbGpPWpGaD
Salbutamol—Insomnia—Triamcinolone—asthma	3.65e-06	9.96e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—BDKRB2—asthma	3.65e-06	0.000671	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL2—asthma	3.64e-06	0.00067	CbGpPWpGaD
Salbutamol—Insomnia—Methylprednisolone—asthma	3.64e-06	9.93e-05	CcSEcCtD
Salbutamol—Infection—Betamethasone—asthma	3.64e-06	9.92e-05	CcSEcCtD
Salbutamol—Infection—Dexamethasone—asthma	3.64e-06	9.92e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—AGTR1—asthma	3.63e-06	0.000668	CbGpPWpGaD
Salbutamol—Ill-defined disorder—Prednisone—asthma	3.63e-06	9.89e-05	CcSEcCtD
Salbutamol—Paraesthesia—Triamcinolone—asthma	3.62e-06	9.88e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Prednisolone—asthma	3.62e-06	9.86e-05	CcSEcCtD
Salbutamol—Paraesthesia—Methylprednisolone—asthma	3.62e-06	9.86e-05	CcSEcCtD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTM1—asthma	3.61e-06	0.000663	CbGpPWpGaD
Salbutamol—Shock—Betamethasone—asthma	3.6e-06	9.83e-05	CcSEcCtD
Salbutamol—Shock—Dexamethasone—asthma	3.6e-06	9.83e-05	CcSEcCtD
Salbutamol—Dyspnoea—Triamcinolone—asthma	3.6e-06	9.81e-05	CcSEcCtD
Salbutamol—Nervous system disorder—Betamethasone—asthma	3.59e-06	9.8e-05	CcSEcCtD
Salbutamol—Nervous system disorder—Dexamethasone—asthma	3.59e-06	9.8e-05	CcSEcCtD
Salbutamol—Agitation—Prednisone—asthma	3.59e-06	9.79e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—KIF3A—asthma	3.58e-06	0.000658	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4A—asthma	3.58e-06	0.000658	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—KNG1—asthma	3.57e-06	0.000657	CbGpPWpGaD
Salbutamol—Tachycardia—Betamethasone—asthma	3.57e-06	9.75e-05	CcSEcCtD
Salbutamol—Tachycardia—Dexamethasone—asthma	3.57e-06	9.75e-05	CcSEcCtD
Salbutamol—Angioedema—Prednisone—asthma	3.57e-06	9.74e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—BDKRB2—asthma	3.57e-06	0.000656	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AGTR1—asthma	3.55e-06	0.000654	CbGpPWpGaD
Salbutamol—Dyspepsia—Triamcinolone—asthma	3.55e-06	9.69e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL10—asthma	3.55e-06	0.000653	CbGpPWpGaD
Salbutamol—Dyspepsia—Methylprednisolone—asthma	3.54e-06	9.67e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Dexamethasone—asthma	3.54e-06	9.66e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Betamethasone—asthma	3.54e-06	9.66e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Hydrocortisone—asthma	3.53e-06	9.63e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—ADCY2—asthma	3.53e-06	0.000649	CbGpPWpGaD
Salbutamol—Malaise—Prednisone—asthma	3.52e-06	9.61e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—IL3—asthma	3.52e-06	0.000647	CbGpPWpGaD
Salbutamol—Vertigo—Prednisone—asthma	3.51e-06	9.58e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Hydrocortisone—asthma	3.5e-06	9.56e-05	CcSEcCtD
Salbutamol—Syncope—Prednisone—asthma	3.5e-06	9.56e-05	CcSEcCtD
Salbutamol—Anorexia—Dexamethasone—asthma	3.49e-06	9.52e-05	CcSEcCtD
Salbutamol—Anorexia—Betamethasone—asthma	3.49e-06	9.52e-05	CcSEcCtD
Salbutamol—Urticaria—Prednisolone—asthma	3.49e-06	9.51e-05	CcSEcCtD
Salbutamol—Fatigue—Triamcinolone—asthma	3.48e-06	9.49e-05	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL10—asthma	3.47e-06	0.000639	CbGpPWpGaD
Salbutamol—Fatigue—Methylprednisolone—asthma	3.47e-06	9.47e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—ADCY2—asthma	3.45e-06	0.000635	CbGpPWpGaD
Salbutamol—Pain—Triamcinolone—asthma	3.45e-06	9.41e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—ADRB2—asthma	3.45e-06	0.000634	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL3—asthma	3.44e-06	0.000633	CbGpPWpGaD
Salbutamol—Loss of consciousness—Prednisone—asthma	3.43e-06	9.37e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—CYSLTR1—asthma	3.42e-06	0.00063	CbGpPWpGaD
Salbutamol—Hypotension—Dexamethasone—asthma	3.42e-06	9.33e-05	CcSEcCtD
Salbutamol—Hypotension—Betamethasone—asthma	3.42e-06	9.33e-05	CcSEcCtD
Salbutamol—Urticaria—Hydrocortisone—asthma	3.4e-06	9.29e-05	CcSEcCtD
Salbutamol—Body temperature increased—Hydrocortisone—asthma	3.39e-06	9.24e-05	CcSEcCtD
Salbutamol—Abdominal pain—Hydrocortisone—asthma	3.39e-06	9.24e-05	CcSEcCtD
Salbutamol—Hypertension—Prednisone—asthma	3.37e-06	9.2e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—CYSLTR1—asthma	3.35e-06	0.000616	CbGpPWpGaD
Salbutamol—Musculoskeletal discomfort—Dexamethasone—asthma	3.34e-06	9.1e-05	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Betamethasone—asthma	3.34e-06	9.1e-05	CcSEcCtD
Salbutamol—Arthralgia—Prednisone—asthma	3.33e-06	9.07e-05	CcSEcCtD
Salbutamol—Myalgia—Prednisone—asthma	3.33e-06	9.07e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Triamcinolone—asthma	3.33e-06	9.07e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—KNG1—asthma	3.32e-06	0.00061	CbGpPWpGaD
Salbutamol—Feeling abnormal—Methylprednisolone—asthma	3.32e-06	9.05e-05	CcSEcCtD
Salbutamol—Anxiety—Prednisone—asthma	3.31e-06	9.04e-05	CcSEcCtD
Salbutamol—Insomnia—Betamethasone—asthma	3.31e-06	9.03e-05	CcSEcCtD
Salbutamol—Insomnia—Dexamethasone—asthma	3.31e-06	9.03e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—C5AR1—asthma	3.31e-06	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CMA1—asthma	3.31e-06	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL11—asthma	3.31e-06	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—UTS2—asthma	3.31e-06	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VIP—asthma	3.31e-06	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AGTR1—asthma	3.3e-06	0.000607	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Methylprednisolone—asthma	3.29e-06	8.98e-05	CcSEcCtD
Salbutamol—Paraesthesia—Dexamethasone—asthma	3.29e-06	8.97e-05	CcSEcCtD
Salbutamol—Paraesthesia—Betamethasone—asthma	3.29e-06	8.97e-05	CcSEcCtD
Salbutamol—Discomfort—Prednisone—asthma	3.29e-06	8.97e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—ITPR1—asthma	3.26e-06	0.000599	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—KNG1—asthma	3.25e-06	0.000597	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—C5AR1—asthma	3.23e-06	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL11—asthma	3.23e-06	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—UTS2—asthma	3.23e-06	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VIP—asthma	3.23e-06	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CMA1—asthma	3.23e-06	0.000595	CbGpPWpGaD
Salbutamol—Hypersensitivity—Prednisolone—asthma	3.23e-06	8.82e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—AGTR1—asthma	3.23e-06	0.000593	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL10—asthma	3.22e-06	0.000593	CbGpPWpGaD
Salbutamol—Dyspepsia—Dexamethasone—asthma	3.22e-06	8.79e-05	CcSEcCtD
Salbutamol—Dyspepsia—Betamethasone—asthma	3.22e-06	8.79e-05	CcSEcCtD
Salbutamol—Urticaria—Triamcinolone—asthma	3.21e-06	8.75e-05	CcSEcCtD
Salbutamol—Urticaria—Methylprednisolone—asthma	3.2e-06	8.73e-05	CcSEcCtD
Salbutamol—Body temperature increased—Triamcinolone—asthma	3.19e-06	8.7e-05	CcSEcCtD
Salbutamol—Anaphylactic shock—Prednisone—asthma	3.19e-06	8.7e-05	CcSEcCtD
Salbutamol—Oedema—Prednisone—asthma	3.19e-06	8.7e-05	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—ITPR1—asthma	3.19e-06	0.000586	CbGpPWpGaD
Salbutamol—Abdominal pain—Methylprednisolone—asthma	3.18e-06	8.68e-05	CcSEcCtD
Salbutamol—Decreased appetite—Betamethasone—asthma	3.18e-06	8.68e-05	CcSEcCtD
Salbutamol—Decreased appetite—Dexamethasone—asthma	3.18e-06	8.68e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—CCR4—asthma	3.17e-06	0.000583	CbGpPWpGaD
Salbutamol—Infection—Prednisone—asthma	3.17e-06	8.64e-05	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Betamethasone—asthma	3.16e-06	8.62e-05	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Dexamethasone—asthma	3.16e-06	8.62e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Hydrocortisone—asthma	3.16e-06	8.61e-05	CcSEcCtD
Salbutamol—Fatigue—Dexamethasone—asthma	3.16e-06	8.61e-05	CcSEcCtD
Salbutamol—Fatigue—Betamethasone—asthma	3.16e-06	8.61e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CXCL10—asthma	3.15e-06	0.00058	CbGpPWpGaD
Salbutamol—Shock—Prednisone—asthma	3.14e-06	8.56e-05	CcSEcCtD
Salbutamol—Pain—Dexamethasone—asthma	3.13e-06	8.54e-05	CcSEcCtD
Salbutamol—Pain—Betamethasone—asthma	3.13e-06	8.54e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—ADRB2—asthma	3.13e-06	0.000576	CbGpPWpGaD
Salbutamol—Nervous system disorder—Prednisone—asthma	3.13e-06	8.53e-05	CcSEcCtD
Salbutamol—Tachycardia—Prednisone—asthma	3.11e-06	8.49e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—STAT6—asthma	3.11e-06	0.000572	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR4—asthma	3.1e-06	0.00057	CbGpPWpGaD
Salbutamol—Skin disorder—Prednisone—asthma	3.1e-06	8.45e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Prednisone—asthma	3.08e-06	8.41e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—EDN1—asthma	3.08e-06	0.000566	CbGpPWpGaD
Salbutamol—Asthenia—Hydrocortisone—asthma	3.07e-06	8.39e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—CCL5—asthma	3.06e-06	0.000562	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL2RB—asthma	3.05e-06	0.000561	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT6—asthma	3.04e-06	0.000559	CbGpPWpGaD
Salbutamol—Anorexia—Prednisone—asthma	3.04e-06	8.29e-05	CcSEcCtD
Salbutamol—Pruritus—Hydrocortisone—asthma	3.03e-06	8.27e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—PDE4D—asthma	3.02e-06	0.000556	CbGpPWpGaD
Salbutamol—Feeling abnormal—Dexamethasone—asthma	3.02e-06	8.23e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Betamethasone—asthma	3.02e-06	8.23e-05	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—EDN1—asthma	3.01e-06	0.000554	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CSF2—asthma	3.01e-06	0.000554	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Dexamethasone—asthma	2.99e-06	8.17e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Betamethasone—asthma	2.99e-06	8.17e-05	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—CCL5—asthma	2.99e-06	0.00055	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL2RB—asthma	2.99e-06	0.000549	CbGpPWpGaD
Salbutamol—Hypersensitivity—Triamcinolone—asthma	2.97e-06	8.11e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Methylprednisolone—asthma	2.97e-06	8.09e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—ITPR1—asthma	2.96e-06	0.000544	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4D—asthma	2.96e-06	0.000544	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TACR1—asthma	2.95e-06	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—C5—asthma	2.95e-06	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4B—asthma	2.95e-06	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CXCL8—asthma	2.95e-06	0.000542	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CSF2—asthma	2.94e-06	0.000542	CbGpPWpGaD
Salbutamol—Diarrhoea—Hydrocortisone—asthma	2.93e-06	8e-05	CcSEcCtD
Salbutamol—Urticaria—Dexamethasone—asthma	2.91e-06	7.94e-05	CcSEcCtD
Salbutamol—Urticaria—Betamethasone—asthma	2.91e-06	7.94e-05	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Prednisone—asthma	2.91e-06	7.93e-05	CcSEcCtD
Salbutamol—Dizziness—Prednisolone—asthma	2.9e-06	7.92e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—ITPR1—asthma	2.9e-06	0.000533	CbGpPWpGaD
Salbutamol—Asthenia—Triamcinolone—asthma	2.9e-06	7.9e-05	CcSEcCtD
Salbutamol—Abdominal pain—Betamethasone—asthma	2.89e-06	7.9e-05	CcSEcCtD
Salbutamol—Body temperature increased—Dexamethasone—asthma	2.89e-06	7.9e-05	CcSEcCtD
Salbutamol—Body temperature increased—Betamethasone—asthma	2.89e-06	7.9e-05	CcSEcCtD
Salbutamol—Abdominal pain—Dexamethasone—asthma	2.89e-06	7.9e-05	CcSEcCtD
Salbutamol—Asthenia—Methylprednisolone—asthma	2.89e-06	7.88e-05	CcSEcCtD
Salbutamol—Insomnia—Prednisone—asthma	2.88e-06	7.87e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—C5—asthma	2.88e-06	0.00053	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4B—asthma	2.88e-06	0.00053	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TACR1—asthma	2.88e-06	0.00053	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CXCL8—asthma	2.88e-06	0.00053	CbGpPWpGaD
Salbutamol—Paraesthesia—Prednisone—asthma	2.86e-06	7.81e-05	CcSEcCtD
Salbutamol—Pruritus—Triamcinolone—asthma	2.86e-06	7.79e-05	CcSEcCtD
Salbutamol—Pruritus—Methylprednisolone—asthma	2.85e-06	7.77e-05	CcSEcCtD
Salbutamol—Dizziness—Hydrocortisone—asthma	2.83e-06	7.73e-05	CcSEcCtD
Salbutamol—Dyspepsia—Prednisone—asthma	2.81e-06	7.66e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—EDN1—asthma	2.8e-06	0.000514	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL5—asthma	2.78e-06	0.00051	CbGpPWpGaD
Salbutamol—Decreased appetite—Prednisone—asthma	2.77e-06	7.56e-05	CcSEcCtD
Salbutamol—Rash—Prednisolone—asthma	2.77e-06	7.55e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—PLA2G4A—asthma	2.76e-06	0.000508	CbGpPWpGaD
Salbutamol—Dermatitis—Prednisolone—asthma	2.76e-06	7.54e-05	CcSEcCtD
Salbutamol—Diarrhoea—Methylprednisolone—asthma	2.75e-06	7.52e-05	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—CCR5—asthma	2.75e-06	0.000506	CbGpPWpGaD
Salbutamol—Fatigue—Prednisone—asthma	2.75e-06	7.5e-05	CcSEcCtD
Salbutamol—Headache—Prednisolone—asthma	2.75e-06	7.5e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—EDN1—asthma	2.74e-06	0.000503	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CSF2—asthma	2.73e-06	0.000503	CbGpPWpGaD
Salbutamol—Constipation—Prednisone—asthma	2.73e-06	7.44e-05	CcSEcCtD
Salbutamol—Vomiting—Hydrocortisone—asthma	2.72e-06	7.43e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CCL5—asthma	2.71e-06	0.000499	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL2RA—asthma	2.71e-06	0.000499	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PLA2G4A—asthma	2.7e-06	0.000497	CbGpPWpGaD
Salbutamol—Rash—Hydrocortisone—asthma	2.7e-06	7.37e-05	CcSEcCtD
Salbutamol—Dermatitis—Hydrocortisone—asthma	2.7e-06	7.36e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—CCR3—asthma	2.7e-06	0.000496	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCR5—asthma	2.69e-06	0.000495	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—C3—asthma	2.69e-06	0.000495	CbGpPWpGaD
Salbutamol—Headache—Hydrocortisone—asthma	2.68e-06	7.32e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CSF2—asthma	2.67e-06	0.000492	CbGpPWpGaD
Salbutamol—Dizziness—Triamcinolone—asthma	2.67e-06	7.28e-05	CcSEcCtD
Salbutamol—Dizziness—Methylprednisolone—asthma	2.66e-06	7.26e-05	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—IL2RA—asthma	2.65e-06	0.000488	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR3—asthma	2.64e-06	0.000485	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—C3—asthma	2.63e-06	0.000484	CbGpPWpGaD
Salbutamol—Feeling abnormal—Prednisone—asthma	2.63e-06	7.17e-05	CcSEcCtD
Salbutamol—Asthenia—Dexamethasone—asthma	2.63e-06	7.17e-05	CcSEcCtD
Salbutamol—Asthenia—Betamethasone—asthma	2.63e-06	7.17e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—NPY—asthma	2.63e-06	0.000483	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Prednisone—asthma	2.61e-06	7.11e-05	CcSEcCtD
Salbutamol—Nausea—Prednisolone—asthma	2.61e-06	7.11e-05	CcSEcCtD
Salbutamol—Pruritus—Betamethasone—asthma	2.59e-06	7.07e-05	CcSEcCtD
Salbutamol—Pruritus—Dexamethasone—asthma	2.59e-06	7.07e-05	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—POMC—asthma	2.59e-06	0.000475	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPY—asthma	2.57e-06	0.000473	CbGpPWpGaD
Salbutamol—Vomiting—Triamcinolone—asthma	2.57e-06	7e-05	CcSEcCtD
Salbutamol—Vomiting—Methylprednisolone—asthma	2.56e-06	6.98e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—PPP2CA—asthma	2.55e-06	0.000468	CbGpPWpGaD
Salbutamol—Nausea—Hydrocortisone—asthma	2.55e-06	6.94e-05	CcSEcCtD
Salbutamol—Rash—Triamcinolone—asthma	2.54e-06	6.94e-05	CcSEcCtD
Salbutamol—Dermatitis—Triamcinolone—asthma	2.54e-06	6.93e-05	CcSEcCtD
Salbutamol—Rash—Methylprednisolone—asthma	2.54e-06	6.93e-05	CcSEcCtD
Salbutamol—Dermatitis—Methylprednisolone—asthma	2.54e-06	6.92e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—AGTR2—asthma	2.53e-06	0.000466	CbGpPWpGaD
Salbutamol—Urticaria—Prednisone—asthma	2.53e-06	6.91e-05	CcSEcCtD
Salbutamol—Headache—Triamcinolone—asthma	2.53e-06	6.9e-05	CcSEcCtD
Salbutamol—Headache—Methylprednisolone—asthma	2.52e-06	6.88e-05	CcSEcCtD
Salbutamol—Abdominal pain—Prednisone—asthma	2.52e-06	6.88e-05	CcSEcCtD
Salbutamol—Body temperature increased—Prednisone—asthma	2.52e-06	6.88e-05	CcSEcCtD
Salbutamol—Diarrhoea—Betamethasone—asthma	2.51e-06	6.83e-05	CcSEcCtD
Salbutamol—Diarrhoea—Dexamethasone—asthma	2.51e-06	6.83e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—CCR5—asthma	2.5e-06	0.00046	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PPP2CA—asthma	2.49e-06	0.000458	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGTR2—asthma	2.48e-06	0.000456	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL2RA—asthma	2.46e-06	0.000453	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCR5—asthma	2.45e-06	0.00045	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—C3—asthma	2.44e-06	0.000449	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LTC4S—asthma	2.44e-06	0.000448	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDNRB—asthma	2.43e-06	0.000446	CbGpPWpGaD
Salbutamol—Dizziness—Dexamethasone—asthma	2.42e-06	6.61e-05	CcSEcCtD
Salbutamol—Dizziness—Betamethasone—asthma	2.42e-06	6.61e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—IL2RA—asthma	2.41e-06	0.000443	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TAC1—asthma	2.4e-06	0.000442	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPS—asthma	2.4e-06	0.000442	CbGpPWpGaD
Salbutamol—Nausea—Triamcinolone—asthma	2.4e-06	6.54e-05	CcSEcCtD
Salbutamol—Nausea—Methylprednisolone—asthma	2.39e-06	6.52e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—C3—asthma	2.39e-06	0.00044	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDNRB—asthma	2.37e-06	0.000437	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCR3—asthma	2.36e-06	0.000433	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPS—asthma	2.35e-06	0.000432	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TAC1—asthma	2.35e-06	0.000432	CbGpPWpGaD
Salbutamol—Hypersensitivity—Prednisone—asthma	2.35e-06	6.41e-05	CcSEcCtD
Salbutamol—Vomiting—Dexamethasone—asthma	2.33e-06	6.35e-05	CcSEcCtD
Salbutamol—Vomiting—Betamethasone—asthma	2.33e-06	6.35e-05	CcSEcCtD
Salbutamol—Rash—Dexamethasone—asthma	2.31e-06	6.3e-05	CcSEcCtD
Salbutamol—Rash—Betamethasone—asthma	2.31e-06	6.3e-05	CcSEcCtD
Salbutamol—Dermatitis—Betamethasone—asthma	2.31e-06	6.29e-05	CcSEcCtD
Salbutamol—Dermatitis—Dexamethasone—asthma	2.31e-06	6.29e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—CXCR3—asthma	2.3e-06	0.000424	CbGpPWpGaD
Salbutamol—Headache—Betamethasone—asthma	2.29e-06	6.26e-05	CcSEcCtD
Salbutamol—Headache—Dexamethasone—asthma	2.29e-06	6.26e-05	CcSEcCtD
Salbutamol—Asthenia—Prednisone—asthma	2.29e-06	6.24e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—CYBA—asthma	2.28e-06	0.00042	CbGpPWpGaD
Salbutamol—Pruritus—Prednisone—asthma	2.26e-06	6.15e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—IL5—asthma	2.23e-06	0.000411	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PARP1—asthma	2.23e-06	0.000411	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CYBA—asthma	2.23e-06	0.00041	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PARP1—asthma	2.18e-06	0.000402	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL5—asthma	2.18e-06	0.000402	CbGpPWpGaD
Salbutamol—Diarrhoea—Prednisone—asthma	2.18e-06	5.95e-05	CcSEcCtD
Salbutamol—Nausea—Dexamethasone—asthma	2.17e-06	5.93e-05	CcSEcCtD
Salbutamol—Nausea—Betamethasone—asthma	2.17e-06	5.93e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—BDKRB2—asthma	2.15e-06	0.000396	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—asthma	2.15e-06	0.000396	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LTA4H—asthma	2.11e-06	0.000389	CbGpPWpGaD
Salbutamol—Dizziness—Prednisone—asthma	2.11e-06	5.75e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—BDKRB2—asthma	2.11e-06	0.000388	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—asthma	2.1e-06	0.000387	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADCY2—asthma	2.09e-06	0.000383	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL3—asthma	2.08e-06	0.000382	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADCY2—asthma	2.04e-06	0.000375	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL3—asthma	2.03e-06	0.000374	CbGpPWpGaD
Salbutamol—Vomiting—Prednisone—asthma	2.03e-06	5.53e-05	CcSEcCtD
Salbutamol—Rash—Prednisone—asthma	2.01e-06	5.48e-05	CcSEcCtD
Salbutamol—Dermatitis—Prednisone—asthma	2.01e-06	5.48e-05	CcSEcCtD
Salbutamol—Headache—Prednisone—asthma	2e-06	5.45e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—KNG1—asthma	1.96e-06	0.000361	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—asthma	1.95e-06	0.000359	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AGTR1—asthma	1.95e-06	0.000358	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KNG1—asthma	1.92e-06	0.000353	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—asthma	1.91e-06	0.000352	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—asthma	1.91e-06	0.000352	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGTR1—asthma	1.91e-06	0.000351	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6R—asthma	1.91e-06	0.000351	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL10—asthma	1.9e-06	0.00035	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—RHOA—asthma	1.9e-06	0.000349	CbGpPWpGaD
Salbutamol—Nausea—Prednisone—asthma	1.89e-06	5.17e-05	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—asthma	1.87e-06	0.000344	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK1—asthma	1.87e-06	0.000344	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6R—asthma	1.86e-06	0.000343	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL10—asthma	1.86e-06	0.000343	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—RHOA—asthma	1.85e-06	0.000341	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADRB2—asthma	1.85e-06	0.00034	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARG1—asthma	1.85e-06	0.00034	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK1—asthma	1.83e-06	0.000336	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITPR1—asthma	1.75e-06	0.000322	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—RHOA—asthma	1.72e-06	0.000317	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITPR1—asthma	1.71e-06	0.000315	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RHOA—asthma	1.68e-06	0.00031	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH7A1—asthma	1.67e-06	0.000307	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CD86—asthma	1.67e-06	0.000306	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL8—asthma	1.66e-06	0.000306	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDN1—asthma	1.65e-06	0.000304	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—asthma	1.64e-06	0.000301	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLA2G4A—asthma	1.63e-06	0.0003	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CD86—asthma	1.63e-06	0.0003	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL8—asthma	1.63e-06	0.000299	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDN1—asthma	1.62e-06	0.000297	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CSF2—asthma	1.61e-06	0.000297	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—asthma	1.6e-06	0.000295	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARG2—asthma	1.6e-06	0.000295	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLA2G4A—asthma	1.6e-06	0.000294	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL2—asthma	1.59e-06	0.000293	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CSF2—asthma	1.58e-06	0.00029	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SMAD3—asthma	1.57e-06	0.000289	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL2—asthma	1.56e-06	0.000286	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SMAD3—asthma	1.54e-06	0.000283	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL8—asthma	1.51e-06	0.000278	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP2CA—asthma	1.5e-06	0.000277	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CXCL8—asthma	1.48e-06	0.000272	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCR5—asthma	1.48e-06	0.000272	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP2CA—asthma	1.47e-06	0.000271	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL2RA—asthma	1.46e-06	0.000268	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR5—asthma	1.44e-06	0.000266	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL2—asthma	1.44e-06	0.000266	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—C3—asthma	1.44e-06	0.000265	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL2RA—asthma	1.42e-06	0.000262	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL2—asthma	1.41e-06	0.00026	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—C3—asthma	1.41e-06	0.00026	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFB—asthma	1.4e-06	0.000258	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFB—asthma	1.37e-06	0.000253	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—asthma	1.34e-06	0.000247	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX5AP—asthma	1.33e-06	0.000244	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX15—asthma	1.33e-06	0.000244	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—asthma	1.31e-06	0.000242	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FN1—asthma	1.27e-06	0.000233	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CHAT—asthma	1.27e-06	0.000233	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FN1—asthma	1.24e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—asthma	1.15e-06	0.000212	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—asthma	1.13e-06	0.000208	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—asthma	1.13e-06	0.000208	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX5—asthma	1.13e-06	0.000208	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6R—asthma	1.13e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—EGFR—asthma	1.1e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—asthma	1.1e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6R—asthma	1.1e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—EGFR—asthma	1.08e-06	0.000199	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CARM1—asthma	1.08e-06	0.000198	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DCN—asthma	1.06e-06	0.000195	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—asthma	1.05e-06	0.000194	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH2—asthma	1.03e-06	0.00019	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—asthma	1.03e-06	0.00019	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RHOA—asthma	1.02e-06	0.000187	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—asthma	1.01e-06	0.000185	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RHOA—asthma	9.95e-07	0.000183	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—asthma	9.85e-07	0.000181	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTT1—asthma	9.82e-07	0.000181	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL8—asthma	8.93e-07	0.000164	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL8—asthma	8.73e-07	0.000161	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL2—asthma	8.53e-07	0.000157	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—asthma	8.49e-07	0.000156	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL2—asthma	8.35e-07	0.000154	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—asthma	8.31e-07	0.000153	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NQO1—asthma	8.16e-07	0.00015	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP9—asthma	8.08e-07	0.000149	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTEN—asthma	8.03e-07	0.000148	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADCY2—asthma	7.99e-07	0.000147	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP9—asthma	7.9e-07	0.000145	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTEN—asthma	7.85e-07	0.000144	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—asthma	7.25e-07	0.000133	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STAT3—asthma	7.18e-07	0.000132	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—asthma	7.09e-07	0.00013	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT3—asthma	7.02e-07	0.000129	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTP1—asthma	6.81e-07	0.000125	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—asthma	6.71e-07	0.000123	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ITPR1—asthma	6.7e-07	0.000123	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—asthma	6.66e-07	0.000122	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAT—asthma	6.62e-07	0.000122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EGFR—asthma	6.53e-07	0.00012	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—asthma	6.51e-07	0.00012	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EGFR—asthma	6.38e-07	0.000117	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G4A—asthma	6.26e-07	0.000115	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—asthma	6.26e-07	0.000115	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPP2CA—asthma	5.76e-07	0.000106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—asthma	5.02e-07	9.22e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—asthma	4.91e-07	9.02e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—asthma	4.42e-07	8.13e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—asthma	4.03e-07	7.41e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—asthma	3.86e-07	7.09e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—asthma	3.53e-07	6.49e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTEN—asthma	3.08e-07	5.66e-05	CbGpPWpGaD
